Based on these findings, further studies are needed to evaluate the prognostic significance of CXCR4/SDF-1 in relation to CD8+ density in different cancers with known prognostic influence of the CXCR4/SDF-1 axis alone, including different types of thyroid cancer. This evidence concerns the gene CXCL12 and cancer.